Longitudinal COVID-19-vaccination-induced antibody responses and Omicron neutralization in patients with lung cancer.

Competing Interests: Declaration of interests The Icahn School of Medicine at Mount Sinai has filed patent applications relating to SARS-CoV-2 serological assays and NDV-based SARS-CoV-2 vaccines, which list F.K. as co-inventor. V.S. is also listed on the serological assay patent application as co-inventor, and A.G.-S. is listed on the NDV-based SARS-CoV-2 vaccine as co-inventor. Mount Sinai has spun out a company, Kantaro, to market serological tests for SARS-CoV-2. F.K. has consulted for Merck and Pfizer (before 2020) and is currently consulting for Pfizer, 3(rd) Rock Ventures, Seqirus, and Avimex. The Krammer laboratory is also collaborating with Pfizer on animal models of SARS-CoV-2. The Adolfo García-Sastre laboratory has received research support from Pfizer, Senhwa Biosciences, Kenall Manufacturing, Avimex, Johnson & Johnson, Dynavax, 7Hills Pharma, Pharmamar, ImmunityBio, Accurius, Nanocomposix, Hexamer, N-fold LLC, Model Medicines, Atea Pharma, and Merck, outside of the reported work. A.G.-S. has consulting agreements for the following companies involving cash and/or stock: Vivaldi Biosciences, Contrafect, 7Hills Pharma, Avimex, Vaxalto, Pagoda, Accurius, Esperovax, Farmak, Applied Biological Laboratories, Pharmamar, and Pfizer, outside of the reported work. J.D.M. acknowledges royalties from the NIH and UT Southwestern Medical Center for distribution of human cell lines. P.C.M. acknowledges honoraria from Amgen and Guardant Health. F.R.H. acknowledges scientific advisory board compensation from AstraZeneca/Daiichi, Genentech, Sanofi/Regeneron, Merck, Bristol-Myers Squibb, Novartis, Amgen, OncoCyte, Nectin Therapeutics, and Novocure. Institutional Research grants (University of Colorado): Amgen, Biodesix, Rain Therapeutics JCK: Advisory Boards: Boehringer Ingelheim, Bristol Myers Squibb, Invitae, Guardant. Institutional Research funding: Bristol Myers Squibb, Genentech, Novartis. C.R.: EMD Serono, AstraZeneca, Roche, Pfizer, Bristol Myer Squibb, Esai, BluePrint, CORE2, Sanofi-Regeneron, Mirati. J.E.G.: Advisory board for Bristol-Myer Squibb.